Cargando…
Novel Biomarkers Associated with Deep Venous Thrombosis: A Comprehensive Review
Primary and recurrent venous thromboembolic disease (VTE, deep venous thrombosis and pulmonary embolism) remain a significant source of morbidity and mortality in the hospitalized patient. Non-specific subjective complaints and lack of specific objective findings related to acute deep venous thrombo...
Autores principales: | Barnes, Dawn M, Wakefield, Thomas W, Rectenwald, John E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699262/ https://www.ncbi.nlm.nih.gov/pubmed/19578498 |
Ejemplares similares
-
Exosomal myeloperoxidase as a biomarker of deep venous thrombosis
por: Han, Yafei, et al.
Publicado: (2022) -
P‐ and E‐ selectin in venous thrombosis and non‐venous pathologies
por: Purdy, Megan, et al.
Publicado: (2022) -
Hepatocyte-derived Microparticles as Novel Biomarkers for the Diagnosis of Deep Venous Thrombosis in Trauma Patients
por: Zang, Xinwei, et al.
Publicado: (2023) -
Identification of thrombomodulin as a dynamic monitoring biomarker for deep venous thrombosis evolution
por: Cheng, Xi, et al.
Publicado: (2021) -
An usual case of bilateral deep venous thrombosis with associated pulmonary embolus
por: Plumptre, Hannah, et al.
Publicado: (2022)